LifeStance Health Statistics Share Statistics LifeStance Health has 388.94M
shares outstanding. The number of shares has increased by 1.63%
in one year.
Shares Outstanding 388.94M Shares Change (YoY) 1.63% Shares Change (QoQ) 1.12% Owned by Institutions (%) 89.57% Shares Floating 148.45M Failed to Deliver (FTD) Shares 11,114 FTD / Avg. Volume 0.42%
Short Selling Information The latest short interest is 7.62M, so 1.96% of the outstanding
shares have been sold short.
Short Interest 7.62M Short % of Shares Out 1.96% Short % of Float 8.83% Short Ratio (days to cover) 3.96
Valuation Ratios The PE ratio is -48.64 and the forward
PE ratio is 131.5.
LifeStance Health's PEG ratio is
0.69.
PE Ratio -48.64 Forward PE 131.5 PS Ratio 2.23 Forward PS 1.3 PB Ratio 1.93 P/FCF Ratio 32.61 PEG Ratio 0.69
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for LifeStance Health.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.37,
with a Debt / Equity ratio of 0.34.
Current Ratio 1.37 Quick Ratio 1.37 Debt / Equity 0.34 Debt / EBITDA 12.17 Debt / FCF 5.66 Interest Coverage -1.19
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $166.02K Profits Per Employee $-7.62K Employee Count 7,535 Asset Turnover 0.59 Inventory Turnover n/a
Taxes Income Tax -170K Effective Tax Rate 0.3%
Stock Price Statistics The stock price has increased by -21.9% in the
last 52 weeks. The beta is 1.17, so LifeStance Health's
price volatility has been higher than the market average.
Beta 1.17 52-Week Price Change -21.9% 50-Day Moving Average 4.94 200-Day Moving Average 6.24 Relative Strength Index (RSI) 54.95 Average Volume (20 Days) 2,617,844
Income Statement In the last 12 months, LifeStance Health had revenue of 1.25B
and earned -57.44M
in profits. Earnings per share was -0.15.
Revenue 1.25B Gross Profit 402.4M Operating Income -31.61M Net Income -57.44M EBITDA 39.87M EBIT -31.08M Earnings Per Share (EPS) -0.15
Full Income Statement Balance Sheet The company has 154.57M in cash and 485.19M in
debt, giving a net cash position of -330.62M.
Cash & Cash Equivalents 154.57M Total Debt 485.19M Net Cash -330.62M Retained Earnings -818.29M Total Assets 2.15B Working Capital 116.56M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 107.26M
and capital expenditures -21.57M, giving a free cash flow of 85.69M.
Operating Cash Flow 107.26M Capital Expenditures -21.57M Free Cash Flow 85.69M FCF Per Share 0.23
Full Cash Flow Statement Margins Gross margin is 32.17%, with operating and profit margins of -2.53% and -4.59%.
Gross Margin 32.17% Operating Margin -2.53% Pretax Margin -4.61% Profit Margin -4.59% EBITDA Margin 3.19% EBIT Margin -2.53% FCF Margin 6.85%
